New antibiotic dosing in infants
- PMID: 25678003
- PMCID: PMC4703883
- DOI: 10.1016/j.clp.2014.10.009
New antibiotic dosing in infants
Abstract
To prevent the devastating consequences of infection, most infants admitted to the neonatal intensive care unit are exposed to antibiotics. However, dosing regimens are often extrapolated from data in adults and older children, increasing the risk for drug toxicity and lack of clinical efficacy because they fail to account for developmental changes in infant physiology. However, newer technologies are emerging with minimal-risk study designs, including ultra-low-volume assays, pharmacokinetic modeling and simulation, and opportunistic drug protocols. With minimal-risk study designs, pharmacokinetic data and dosing regimens for infants are now available for ampicillin, clindamycin, meropenem, metronidazole, and piperacillin/tazobactam.
Keywords: Antibiotics; Dosing; Infants; Neonates; Pharmacokinetics; Prematurity.
Copyright © 2015 Elsevier Inc. All rights reserved.
Conflict of interest statement
Similar articles
-
Dosing antibiotics in neonates: review of the pharmacokinetic data.Future Microbiol. 2017 Sep;12(11):1001-1016. doi: 10.2217/fmb-2017-0058. Epub 2017 Jul 31. Future Microbiol. 2017. PMID: 28758800 Free PMC article.
-
Cefepime restriction improves gram-negative overall resistance patterns in neonatal intensive care unit.Braz J Infect Dis. 2007 Apr;11(2):277-80. doi: 10.1590/s1413-86702007000200022. Braz J Infect Dis. 2007. PMID: 17625777
-
Population pharmacokinetics of piperacillin/tazobactam in neonates and young infants.Eur J Clin Pharmacol. 2013 Jun;69(6):1223-33. doi: 10.1007/s00228-012-1413-4. Epub 2013 Jan 26. Eur J Clin Pharmacol. 2013. PMID: 23354809 Clinical Trial.
-
[Pharmacological properties and clinical efficacies of tazobactam/piperacillin (Zosyn 2.25, Zosyn 4.5), an injectable antibiotic combined with beta-lactamase inhibitor].Nihon Yakurigaku Zasshi. 2009 Jun;133(6):351-8. doi: 10.1254/fpj.133.351. Nihon Yakurigaku Zasshi. 2009. PMID: 19521033 Review. Japanese. No abstract available.
-
Pharmacokinetic evaluation of piperacillin-tazobactam.Expert Opin Drug Metab Toxicol. 2010 Aug;6(8):1017-31. doi: 10.1517/17425255.2010.506187. Expert Opin Drug Metab Toxicol. 2010. PMID: 20636224 Review.
Cited by
-
Management of early- and late-onset sepsis: results from a survey in 80 German NICUs.Infection. 2019 Aug;47(4):557-564. doi: 10.1007/s15010-018-1263-9. Epub 2019 Jan 3. Infection. 2019. PMID: 30607897
-
Population Pharmacokinetics and Dosage Optimization of Linezolid in Critically Ill Pediatric Patients.Antimicrob Agents Chemother. 2023 May 1;95(5):e02504-20. doi: 10.1128/AAC.02504-20. Epub 2021 Feb 8. Antimicrob Agents Chemother. 2023. PMID: 33558298 Free PMC article.
-
CDC Guidelines for the Prevention and Treatment of Anthrax, 2023.MMWR Recomm Rep. 2023 Nov 17;72(6):1-47. doi: 10.15585/mmwr.rr7206a1. MMWR Recomm Rep. 2023. PMID: 37963097 Free PMC article.
-
Dosing antibiotics in neonates: review of the pharmacokinetic data.Future Microbiol. 2017 Sep;12(11):1001-1016. doi: 10.2217/fmb-2017-0058. Epub 2017 Jul 31. Future Microbiol. 2017. PMID: 28758800 Free PMC article.
-
Dual alarmin-receptor-specific targeting peptide systems for treatment of sepsis.Acta Pharm Sin B. 2024 Dec;14(12):5451-5463. doi: 10.1016/j.apsb.2024.08.015. Epub 2024 Aug 19. Acta Pharm Sin B. 2024. PMID: 39807314 Free PMC article.
References
-
- Stoll BJ, Hansen N, Fanaroff AA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics. 2002;110:285–291. - PubMed
-
- Stoll BJ, Hansen NI, Higgins RD, et al. Very low birth weight preterm infants with early onset neonatal sepsis: the predominance of gram-negative infections continues in the National Institute of Child Health and Human Development Neonatal Research Network, 2002–2003. Pediatr Infect Dis J. 2005;24:635–639. - PubMed
-
- Silveira RC, Procianoy RS, Dill JC, da Costa CS. Periventricular leukomalacia in very low birth weight preterm neonates with high risk for neonatal sepsis. J Pediatr (Rio J) 2008;84:211–216. - PubMed
-
- Clark RH, Bloom BT, Spitzer AR, Gerstmann DR. Reported medication use in the neonatal intensive care unit: data from a large national data set. Pediatrics. 2006;117:1979–1987. - PubMed
-
- Kearns GL, Abdel-Rahman SM, Alander SW, Blowey DL, Leeder JS, Kauffman RE. Developmental pharmacology--drug disposition, action, and therapy in infants and children. N Engl J Med. 2003;349:1157–1167. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical